Trump: USMCA Trade Deal Faces Expiry or New Agreement
Former President Donald Trump states the USMCA trade pact will either expire or be renegotiated in its upcoming 2025 review. Get the latest on this critical trade development.
Former President Donald Trump states the USMCA trade pact will either expire or be renegotiated in its upcoming 2025 review. Get the latest on this critical trade development.
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
With terms of 325 Panchayat Samitis ending on Dec 10, Rajasthan's Pradhans urge the state to appoint interim administrators to prevent a rural development halt. Read their demands.
Punjab & Haryana High Court rules driving licences remain valid for 30 days after expiry. Accident on grace period's final day is covered by insurance. Read key details.
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
Dr. Rajeev Sharma from Himachal Dental College receives UK design patent for innovative medical utility tray. Breakthrough in medical device innovation from Indian professor.
Kajol and Twinkle Khanna's talk show 'Two Much' concluded after 8 candid episodes, sparking debates on infidelity and marriage. A special bonus with cricketers released post-season.
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Indian renewable energy company secures patent for EV charging technology, boosting stock by 5%. Details on innovation and market impact revealed.
Michelle Obama faces Ozempic rumors after revealing slimmer frame in Annie Leibovitz photoshoot. Social media erupts with speculation despite no evidence. Read the full story.
Indian IT giants TCS and Wipro face fresh patent lawsuits in Texas courts over cloud and telecom technologies. Legal challenges mount as firms expand into software products. Read analysis.
ICAR patents indigenous TnpB gene editing technology, offering a miniature alternative to CRISPR. This breakthrough promises cheaper, IP-free GE crop development for Indian farmers.
Kaynes Technology India shares fell nearly 6% as lock-in period ended, freeing 11.6M shares worth ₹7,233 crore. Company shows strong Q2 growth with profit up 102%. Read analysis.
US ITC investigates Apple's redesigned blood oxygen feature. Potential import ban on Series 9, Series 10 & Ultra 2 watches could disrupt holiday sales. Latest update on $634M patent battle.
Students from Chandigarh's Satluj School secure patent for portable medical device. Learn how this innovation addresses critical healthcare challenges in remote areas.
Ajay Devgn says unconditional love exists only for pets, while wife Kajol believes marriages need expiry dates. Read about their contrasting views on modern relationships.
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
India's market regulator SEBI announces major reforms in short selling framework, introducing weekly expiry F&O contracts, mandatory securities lending, and stricter disclosure norms for investors.
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
US technology firm Adeia sues AMD for alleged patent infringement, demanding fair licensing terms for semiconductor innovations. Get the full story on this major tech legal battle.
Discover why molecule-based weight loss supplements are going viral among young Russians. Learn about the science, risks, and expert warnings about this concerning health trend.
Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.
Discover how GLP-1 receptor agonists are revolutionizing diabetes and obesity treatment. Learn the mechanism behind popular drugs like Ozempic, Mounjaro, and other game-changing medications.
Samsung is developing a revolutionary tri-folding smartphone that could become the slimmest foldable device ever, potentially beating the upcoming Galaxy Z Fold 7 in both innovation and design.
Perplexity AI CEO Aravind Srinivas unveils revolutionary AI-powered patent research tool that transforms how innovators search and analyze patents with natural language queries.
Bengaluru medical experts sound alarm on diabetes drugs being misused for weight loss, highlighting dangerous side effects and long-term health risks.